ECDC is publishing the first external quality assurance scheme (EQA) for Bordetalla pertusis PCR,  participated by 21-one laboratories from 21 European Union/European Economic Area countries.

This report presents the results of the first external quality assurance (EQA) scheme for Bordetella identification and typing funded by the European Centre for Disease Prevention and Control (ECDC).

This report presents the results of an external quality assurance (EQA) scheme for Bordetella pertussis serology which was carried out during the summer of 2013.

This external quality assessment (EQA) to assess the ability of national reference laboratories from EU/EEA Member States to correctly perform laboratory serodiagnostic tests for pertussis was a collaborative study organised from February to April 2016.

This report presents the results of the second European Pertussis Laboratory Surveillance Network (EUPert-LabNet) EQA scheme for Bordetella pertussis PCR funded by ECDC on behalf of EUPert-LabNet. The EQA study was conducted between February and March 2018.